stock price decline

Law firm investigates Ralliant's $1.4B goodwill impairment on EA Elektro-Automatik acquisition. Stock plummeted 31.79% amid scrutiny over disclosure adequacy and valuation assumptions.

BlackRock TCP Capital faces class action lawsuit over NAV understatement and portfolio valuation discrepancies. Investor deadline to join is April 6, 2026.

Pomerantz Law Firm sues Agilon Health for securities fraud following CEO resignation and 51% stock decline after guidance suspension.

Pomerantz Law Firm investigates Pharming Group after FDA rejects pediatric drug application, causing 17% stock decline. Inquiry focuses on whether regulatory risks were adequately disclosed to investors.

Pomerantz LLP sues Ardent Health for securities fraud over November 2025 disclosures revealing $43M revenue decrease and $57.5M EBITDA cut, causing 33.81% stock decline. Shareholders can join by March 9.

Vistagen faces class action lawsuit after Phase 3 trial failure for anxiety drug. Stock plunged 80%. Investors must act by March 16, 2026 deadline.

NuScale Power faces securities fraud lawsuit over alleged misrepresentations about its ENTRA1 Energy partnership. Stock fell 70% after November 2025 disclosures of $495M payment and $532M loss.

Law firm investigates Alvotech after FDA rejected applications following failed facility inspection, causing stock to plunge 34%. Investors sought for potential securities litigation.

Law firm investigates Gemini Space Station after three senior executives abruptly resigned, causing stock to plummet 12.83%. Probe examines potential securities law violations.

Navan faces class action lawsuit over alleged IPO disclosure failures regarding undisclosed marketing spending plans. Stock plunged 63% after December earnings announcement revealed 39% expense increase.

Kyndryl faces class action lawsuit for allegedly issuing false financial statements and maintaining inadequate accounting controls, following a 50% stock drop in February 2026.

Portnoy Law Firm sues Richtech Robotics for falsely claiming Microsoft partnership. Stock fell 29% after Microsoft denied commercial relationship, causing investor losses.

Richtech Robotics faces securities lawsuit for misrepresenting Microsoft partnership scope. Stock dropped 29% after Microsoft clarified their relationship was limited to standard AI collaboration.

GSI Technology faces securities investigation for allegedly making false claims about chip capabilities. Stock dropped 14.2% after disclosure that semiconductor couldn't run promised software.

Varonis faces class action lawsuit over allegedly misleading statements about revenue sustainability. Investors have until March 9 to join after stock plunged 48.7%.

PayPal faces securities lawsuit alleging false revenue statements. Investors must file claims by April 20, 2026, following a 20.3% stock decline.

Fermi Inc. stock plunged 33% after terminating a $150 million customer agreement. A securities fraud lawsuit was filed alleging misrepresentations in its IPO documents.

SentinelOne CEO sold $532K in shares via pre-arranged plan amid 43% stock decline. Stock trades at attractive valuations as company approaches $1B revenue milestone.

PennyMac Financial faces securities investigation for allegedly misleading investors about servicing segment performance. Stock plummeted 33% after fourth quarter earnings decline.

Corcept Therapeutics faces class action lawsuit over alleged misrepresentation regarding relacorilant drug. FDA rejected the application citing insufficient efficacy data; stock plummeted over 50%.